212 related articles for article (PubMed ID: 28885995)
1. Glucagon-Like Peptide-1 (GLP-1) Treatment Ameliorates Cognitive Impairment by Attenuating Arc Expression in Type 2 Diabetic Rats.
Cai XS; Tan ZG; Li JJ; Gao WH; Li SJ; Li JL; Tang YM; Li HW; Hui HX
Med Sci Monit; 2017 Sep; 23():4334-4342. PubMed ID: 28885995
[TBL] [Abstract][Full Text] [Related]
2. [Glucagon-like peptide 1 improves learning and memory abilities of rats with type 2 diabetes].
Tan ZG; Gao WH; Cai XS; Wang F; Hui HX
Nan Fang Yi Ke Da Xue Xue Bao; 2016 Oct; 36(10):1345-1351. PubMed ID: 27777196
[TBL] [Abstract][Full Text] [Related]
3. Rosa canina L. improves learning and memory-associated cognitive impairment by regulating glucose levels and reducing hippocampal insulin resistance in high-fat diet/streptozotocin-induced diabetic rats.
Ertas B; Hazar-Yavuz AN; Topal F; Keles-Kaya R; Karakus Ö; Ozcan GS; Taskin T; Cam ME
J Ethnopharmacol; 2023 Sep; 313():116541. PubMed ID: 37088237
[TBL] [Abstract][Full Text] [Related]
4. Reduction in TNF alpha and oxidative stress by liraglutide: Impact on ketamine-induced cognitive dysfunction and hyperlocomotion in rats.
Sedky AA; Magdy Y
Life Sci; 2021 Aug; 278():119523. PubMed ID: 33891942
[TBL] [Abstract][Full Text] [Related]
5. Ferulic acid attenuates diabetes-induced cognitive impairment in rats via regulation of PTP1B and insulin signaling pathway.
Wang H; Sun X; Zhang N; Ji Z; Ma Z; Fu Q; Qu R; Ma S
Physiol Behav; 2017 Dec; 182():93-100. PubMed ID: 28988132
[TBL] [Abstract][Full Text] [Related]
6. DA5-CH, a novel GLP-1/GIP dual agonist, effectively ameliorates the cognitive impairments and pathology in the APP/PS1 mouse model of Alzheimer's disease.
Cao Y; Hölscher C; Hu MM; Wang T; Zhao F; Bai Y; Zhang J; Wu MN; Qi JS
Eur J Pharmacol; 2018 May; 827():215-226. PubMed ID: 29551659
[TBL] [Abstract][Full Text] [Related]
7. Protection of cholinergic and antioxidant system contributes to the effect of berberine ameliorating memory dysfunction in rat model of streptozotocin-induced diabetes.
Bhutada P; Mundhada Y; Bansod K; Tawari S; Patil S; Dixit P; Umathe S; Mundhada D
Behav Brain Res; 2011 Jun; 220(1):30-41. PubMed ID: 21262264
[TBL] [Abstract][Full Text] [Related]
8. Telmisartan treatment ameliorates memory deficits in streptozotocin-induced diabetic mice via attenuating cerebral amyloidosis.
Du GT; Hu M; Mei ZL; Wang C; Liu GJ; Hu M; Long Y; Miao MX; Chang Li J; Hong H
J Pharmacol Sci; 2014; 124(4):418-26. PubMed ID: 24671053
[TBL] [Abstract][Full Text] [Related]
9. Tanshinone IIA exerts neuroprotective effects on hippocampus-dependent cognitive impairments in diabetic rats by attenuating ER stress-induced apoptosis.
Chen J; Bi Y; Chen L; Zhang Q; Xu L
Biomed Pharmacother; 2018 Aug; 104():530-536. PubMed ID: 29800917
[TBL] [Abstract][Full Text] [Related]
10. Liraglutide prevents cognitive decline in a rat model of streptozotocin-induced diabetes independently from its peripheral metabolic effects.
Palleria C; Leo A; Andreozzi F; Citraro R; Iannone M; Spiga R; Sesti G; Constanti A; De Sarro G; Arturi F; Russo E
Behav Brain Res; 2017 Mar; 321():157-169. PubMed ID: 28062257
[TBL] [Abstract][Full Text] [Related]
11. Val8-glucagon-like peptide-1 protects against Aβ1-40-induced impairment of hippocampal late-phase long-term potentiation and spatial learning in rats.
Wang XH; Li L; Hölscher C; Pan YF; Chen XR; Qi JS
Neuroscience; 2010 Nov; 170(4):1239-48. PubMed ID: 20727946
[TBL] [Abstract][Full Text] [Related]
12. GLP-1 Treatment Improves Diabetic Retinopathy by Alleviating Autophagy through GLP-1R-ERK1/2-HDAC6 Signaling Pathway.
Cai X; Li J; Wang M; She M; Tang Y; Li J; Li H; Hui H
Int J Med Sci; 2017; 14(12):1203-1212. PubMed ID: 29104476
[No Abstract] [Full Text] [Related]
13. Effect of GLP-1 treatment on GLUT2 and GLUT4 expression in type 1 and type 2 rat diabetic models.
Villanueva-Peñacarrillo ML; Puente J; Redondo A; Clemente F; Valverde I
Endocrine; 2001 Jul; 15(2):241-8. PubMed ID: 11720253
[TBL] [Abstract][Full Text] [Related]
14. Meloxicam Improves Cognitive Impairment of Diabetic Rats through COX2-PGE2-EPs-cAMP/pPKA Pathway.
Li H; Luo Y; Xu Y; Yang L; Hu C; Chen Q; Yang Y; Ma J; Zhang J; Xia H; Li Y; Yang J
Mol Pharm; 2018 Sep; 15(9):4121-4131. PubMed ID: 30109938
[TBL] [Abstract][Full Text] [Related]
15. Cinepazide Maleate Improves Cognitive Function and Protects Hippocampal Neurons in Diabetic Rats with Chronic Cerebral Hypoperfusion.
Li Y; Zhang T; Zhang X; Zou W; Gong X; Fu J
Biol Pharm Bull; 2017 Mar; 40(3):249-255. PubMed ID: 27990002
[TBL] [Abstract][Full Text] [Related]
16. Exendin-4 improves behaviorial deficits via GLP-1/GLP-1R signaling following partial hepatectomy.
Zhou Y; Li Z; Cao X; Ma H; White PF; Xu X; Jiang Y; Sun X; Cui Y
Brain Res; 2019 Mar; 1706():116-124. PubMed ID: 30408479
[TBL] [Abstract][Full Text] [Related]
17. Exenatide upregulates gene expression of glucagon-like peptide-1 receptor and nerve growth factor in streptozotocin/nicotinamide-induced diabetic mice.
Gumuslu E; Cine N; Ertan M; Mutlu O; Komsuoglu Celikyurt I; Ulak G
Fundam Clin Pharmacol; 2018 Apr; 32(2):174-180. PubMed ID: 29091313
[TBL] [Abstract][Full Text] [Related]
18. GLP-1 effect upon the GPI/IPG system in adipocytes and hepatocytes from diabetic rats.
Márquez L; González N; Puente J; Valverde L; Villanueva-Peñacarrillo ML
Diabetes Nutr Metab; 2001 Oct; 14(5):239-44. PubMed ID: 11806463
[TBL] [Abstract][Full Text] [Related]
19. Chrysophanol Relieves Cognition Deficits and Neuronal Loss Through Inhibition of Inflammation in Diabetic Mice.
Chu X; Zhou S; Sun R; Wang L; Xing C; Liang R; Kong Q
Neurochem Res; 2018 Apr; 43(4):972-983. PubMed ID: 29497904
[TBL] [Abstract][Full Text] [Related]
20. Effects of L-3-n-butylphthalide on cognitive dysfunction and NR2B expression in hippocampus of streptozotocin (STZ)-induced diabetic rats.
Li J; Zhang S; Zhang L; Wang R; Wang M
Cell Biochem Biophys; 2015 Jan; 71(1):315-22. PubMed ID: 25149651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
